10.69
price down icon2.91%   -0.32
after-market After Hours: 10.70 0.010 +0.09%
loading
Zevra Therapeutics Inc stock is traded at $10.69, with a volume of 1.77M. It is down -2.91% in the last 24 hours and up +37.94% over the past month. Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
See More
Previous Close:
$11.01
Open:
$10.71
24h Volume:
1.77M
Relative Volume:
0.98
Market Cap:
$600.08M
Revenue:
$27.46M
Net Income/Loss:
$-46.05M
P/E Ratio:
-8.2868
EPS:
-1.29
Net Cash Flow:
$-33.83M
1W Performance:
+0.38%
1M Performance:
+37.94%
6M Performance:
+54.93%
1Y Performance:
+31.00%
1-Day Range:
Value
$10.40
$10.89
1-Week Range:
Value
$9.93
$11.23
52-Week Range:
Value
$6.19
$13.16

Zevra Therapeutics Inc Stock (ZVRA) Company Profile

Name
Name
Zevra Therapeutics Inc
Name
Phone
(321) 939-3416
Name
Address
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Name
Employee
59
Name
Twitter
Name
Next Earnings Date
2025-03-11
Name
Latest SEC Filings
Name
ZVRA's Discussions on Twitter

Compare ZVRA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ZVRA
Zevra Therapeutics Inc
10.69 618.05M 27.46M -46.05M -33.83M -1.29
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-02-25 Initiated H.C. Wainwright Buy
Jan-08-25 Resumed Cantor Fitzgerald Overweight
Oct-07-24 Initiated Guggenheim Buy
Sep-24-24 Initiated JMP Securities Mkt Outperform
Sep-24-24 Reiterated Maxim Group Buy
Apr-02-24 Reiterated Maxim Group Buy
Mar-12-24 Initiated William Blair Outperform
Mar-17-23 Initiated Maxim Group Buy
View All

Zevra Therapeutics Inc Stock (ZVRA) Latest News

pulisher
10:45 AM

Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap Down Following Insider Selling - MarketBeat

10:45 AM
pulisher
10:10 AM

What the charts say about Zevra Therapeutics Inc. today2025 Dividend Review & Weekly Top Performers Watchlists - newser.com

10:10 AM
pulisher
08:42 AM

Using economic indicators to assess Zevra Therapeutics Inc. potentialStop Loss & Weekly Top Stock Performers List - newser.com

08:42 AM
pulisher
04:09 AM

Should you wait for a breakout in Zevra Therapeutics Inc.Analyst Downgrade & Entry and Exit Point Strategies - newser.com

04:09 AM
pulisher
01:48 AM

Will breakout in Zevra Therapeutics Inc. lead to full recoveryProduct Launch & Low Drawdown Momentum Trade Ideas - newser.com

01:48 AM
pulisher
Oct 12, 2025

What to do if you’re stuck in Zevra Therapeutics Inc.Market Trend Summary & Reliable Momentum Entry Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Insider Selling: Zevra Therapeutics (NASDAQ:ZVRA) CEO Sells 19,500 Shares of Stock - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call - 富途牛牛

Oct 11, 2025
pulisher
Oct 11, 2025

Zevra Therapeutics, Inc. $ZVRA Position Cut by Janney Montgomery Scott LLC - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Zevra Therapeutics CEO Neil McFarlane sells $210k in shares By Investing.com - Investing.com Nigeria

Oct 11, 2025
pulisher
Oct 10, 2025

Zevra Therapeutics CEO Neil McFarlane sells $210k in shares - Investing.com India

Oct 10, 2025
pulisher
Oct 10, 2025

Can Zevra Therapeutics Inc. (1GDA) stock sustain breakout momentumDip Buying & Stepwise Trade Signal Implementation - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How moving averages guide Zevra Therapeutics Inc. tradingJuly 2025 Summary & Stock Timing and Entry Methods - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Zevra Therapeutics Inc. (1GDA) stock test record highs in 2025Trade Risk Report & AI Enhanced Trade Execution Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Chart overlay techniques for tracking Zevra Therapeutics Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What moving averages say about Zevra Therapeutics Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Zevra Therapeutics (ZVRA): Evaluating Valuation Following Insider Buying and Sustained Revenue Growth - Yahoo

Oct 10, 2025
pulisher
Oct 09, 2025

Zevra Therapeutics gains amid takeover speculation - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Why global investors buy Zevra Therapeutics Inc. (1GDA) stock2025 Key Highlights & AI Enhanced Trading Signals - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Using RSI to spot recovery in Zevra Therapeutics Inc.Earnings Risk Report & Long-Term Investment Growth Plans - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

What drives Zevra Therapeutics Inc stock priceBearish Engulfing Patterns & Breakout Portfolio Performance - earlytimes.in

Oct 07, 2025
pulisher
Oct 07, 2025

What drives Zevra Therapeutics Inc 1GDA stock priceEx-Dividend Date Alerts & Affordable Market Growth - earlytimes.in

Oct 07, 2025
pulisher
Oct 07, 2025

The Three-year Returns Have Been Decent for Zevra Therapeutics (NASDAQ:ZVRA) Shareholders Despite Underlying Losses Increasing - 富途牛牛

Oct 07, 2025
pulisher
Oct 06, 2025

Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 06, 2025
pulisher
Oct 06, 2025

38,000-Share Inducement: Zevra Therapeutics Awards Options to Two New Hires, Vesting Over 4 Years - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

Zevra Therapeutics (NASDAQ:ZVRA) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Zevra Therapeutics' Stock Soars on Strong Performance and Strategic Wins: What It Means for Investors - FinancialContent

Oct 06, 2025
pulisher
Oct 06, 2025

Will Zevra Therapeutics Inc. rebound enough to break evenMarket Weekly Review & Weekly High Conviction Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Zevra Therapeutics Inc. (1GDA) stock a top dividend aristocrat candidateInflation Watch & Free Risk Controlled Daily Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Zevra Therapeutics Inc. (1GDA) stock benefit from Fed rate cutsCPI Data & Community Consensus Stock Picks - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Zevra Therapeutics Inc. (1GDA) stock a buy for dividend portfoliosJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Visual trend scoring systems applied to Zevra Therapeutics Inc.2025 Major Catalysts & Fast Gain Stock Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How to use a screener to detect Zevra Therapeutics Inc. breakoutsQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Zevra Therapeutics (NASDAQ:ZVRA) Rating Lowered to Hold at Wall Street Zen - Defense World

Oct 05, 2025
pulisher
Oct 05, 2025

Will Zevra Therapeutics Inc. (1GDA) stock draw ESG focused funds2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can trapped investors hope for a rebound in Zevra Therapeutics Inc.Trade Volume Report & Weekly Setup with ROI Potential - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

How Zevra Therapeutics Inc. (1GDA) stock trades in high volatilityJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How Investors May Respond To Zevra Therapeutics (ZVRA) European Review of MIPLYFFA for Rare Disease Expansion - Sahm

Oct 03, 2025
pulisher
Oct 02, 2025

How institutional ownership impacts Zevra Therapeutics Inc. stockEarnings Overview Summary & Smart Money Movement Alerts - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

Daily Brief United States: Rocket Lab USA , Northwest Biotherapeutics, Fermi, Occidental Petroleum, Intel Corp, Zevra Therapeutics , UP Fintech, Rogers Corp, Rollins Inc, Lockheed Martin and more - Smartkarma

Oct 01, 2025

Zevra Therapeutics Inc Stock (ZVRA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):